Megan Hottell, SLP-CCC | |
6150 Highway 79, Guston, KY 40142-7009 | |
(270) 991-8032 | |
Not Available |
Full Name | Megan Hottell |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 6150 Highway 79, Guston, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376264879 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 268904 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Megan Hottell, SLP-CCC 6150 Highway 79, Guston, KY 40142-7009 Ph: (270) 991-8032 | Megan Hottell, SLP-CCC 6150 Highway 79, Guston, KY 40142-7009 Ph: (270) 991-8032 |
News Archive
Older men with low testosterone levels who received testosterone supplementation increased lean body mass and decreased body fat, but were no stronger and had no improvement in mobility or cognition compared with men who did not use the supplement, according to a study in the January 2 issue of JAMA.
Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.
Pheromones are like the molecules you taste as you chomp on a greasy french fry: big and fatty.
A one-dose method for delivering gene therapy into an arterial wall effectively protects the artery from developing atherosclerosis despite ongoing high blood cholesterol.
› Verified 4 days ago
Mrs. Rebecca Kathleen Thompson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12050 Highway 60, Guston, KY 40142 Phone: 270-899-0222 |